Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Elevating Nephrology Outcomes at #ERA23

    Press Releases | June 15, 2023 | Medscape Education

    Medscape is headed back to Milano, Italy for the 2023 European Renal Association conference, #ERA23.This year, the team is elevating the outcomes of recent nephrology education programs to share the story...

    From Multichannel to Omnichannel

    White Papers and Resources | June 13, 2023 | Mednet

    Take a look at the movement to omnichannel communication

    How to Increase Engagement During Virtual Events

    Videos and Podcasts | June 8, 2023 | Impetus Digital

    Here's tip 8 of 10 on how to increase engagement during virtual events. Learn more tips at  https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To find out more about how Impetus Digital can aid pharma and life...

    Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023

    Press Releases | June 6, 2023 | Medscape Education

    The Medscape Education team will be on site at the 2023 EHA conference in Frankfurt, Germany to share the outcomes of recent hematology education programs and to advance the discussion on...

    Archetypes: Rethinking go-to-market expectations to drive commercial success

    White Papers and Resources | June 6, 2023 | Avalere Health

    In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

    Navigating patients step by step on their clinical trial journey

    Videos and Podcasts | June 5, 2023 | Innovative Trials

    For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

    Innovative Trials responds to national recommendations to tackle UK clinical trial decline

    Press Releases | June 5, 2023 | Innovative Trials

    Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

    Whitepaper: Closing the gap with compelling healthcare communications

    White Papers and Resources | June 3, 2023 | Page & Page Health

    Want to learn how to close the distance between a person’s current health and their healthiest possible self?

    Healing the Healers

    White Papers and Resources | June 2, 2023 | Havas Lynx

    Because if we do not heal the healers, who is going to heal us?

    The (inevitable) digital transformation of Medical Affairs

    White Papers and Resources | June 1, 2023 | Impetus Digital

    It’s not a question of ‘if,’ it’s a question of ‘when.’